Uroqid-Acid No.2
RxNorm concept 220703, brand name (bn).
- RxCUI
- 220703
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/220703 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- methenamine mandelate (PIN, has precise ingredient)
- methenamine / sodium phosphate, monobasic Oral Tablet [Uroqid-Acid No.2] (SBDF, ingredient of)
- methenamine mandelate 500 MG / sodium phosphate, monobasic 500 MG [Uroqid-Acid No.2] (SBDC, ingredient of)
- methenamine mandelate 500 MG / sodium phosphate, monobasic 500 MG Oral Tablet [Uroqid-Acid No.2] (SBD, ingredient of)
- Uroqid-Acid No.2 Oral Product (SBDG, ingredient of)
- Uroqid-Acid No.2 Pill (SBDG, ingredient of)
- methenamine (IN, tradename of)
- sodium phosphate, monobasic (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 220703 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/220703 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 220703. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.